May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

Regular Exercise Slows Memory Decline in Seniors

In a study of older adults with memory problems, those who exercised regularly for 12 months had less cognitive decline than those who did not receive any intervention.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 22, 2025

HSV-1 Tied to Alzheimer’s: Study

In a matched case–control study of over 340,000 patients, researchers found that adults diagnosed with herpes simplex virus type 1 had higher odds of developing Alzheimer’s disease.

Conexiant

May 19, 2025

HIV/Hepatitis B Drug Class Shows Promise Against Alzheimer's

A longitudinal study across two major U.S. health databases found nucleoside reverse transcriptase inhibitors to be associated with reduced Alzheimer's disease incidence.

Conexiant

May 19, 2025

CAA Imaging Markers Linked to Plasma Biomarkers

A large cohort study in South Korea found that cerebral amyloid angiopathy imaging markers were linked to increased Alzheimer’s-related plasma biomarkers and cognitive decline, partly mediated by brain amyloid buildup.

Conexiant

May 16, 2025

FDA Clears First Blood Test for Alzheimer’s

The FDA has cleared the first blood-based test to aid in diagnosing Alzheimer’s disease, offering a less invasive alternative to positron emission tomography scans and cerebrospinal fluid testing for cognitively impaired patients.

Conexiant

May 16, 2025

Recognizing Alzheimer’s Comorbidities 'Crucial'

Researchers analyzed medical records of over 2500 Alzheimer’s patients and found most comorbidities, like hypertension and hyperlipidemia, began before diagnosis—except for depression, which was diagnosed afterward.

Conexiant